Oncoplastic Breast Surgery Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—4

Registered number: 10652816

		2026		2025
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		1,448		2,560

			1,448		2,560
CURRENT ASSETS
Debtors	5	13,864		9,334
Cash at bank and in hand		228,908		223,799

		242,772		233,133
Creditors: Amounts Falling Due Within One Year	6	(49,645 )		(49,684 )

NET CURRENT ASSETS (LIABILITIES)			193,127		183,449

TOTAL ASSETS LESS CURRENT LIABILITIES			194,575		186,009

PROVISIONS FOR LIABILITIES
Deferred Taxation	7		(275 )		(486 )

NET ASSETS			194,300		185,523

CAPITAL AND RESERVES
Called up share capital	9		200		150
Profit and Loss Account			194,100		185,373

SHAREHOLDERS' FUNDS			194,300		185,523

Page 1

Page 2

Oncoplastic Breast Surgery Limited

Balance Sheet (continued)

As At 31 March 2026

For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr A Goyal

Director

08/10/2026

The notes on pages 3 to 4 form part of these financial statements.

1. General Information

Oncoplastic Breast Surgery Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10652816 . The registered office is 255 Derby Road, Long Eaton, Nottingham, NG10 4BS.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

2.3. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Fixtures & Fittings	15% on cost
Computer Equipment	25% on cost

2.4. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 3 (2025: 3)

4. Tangible Assets

	Fixtures & Fittings	Computer Equipment	Total
	£	£	£
Cost
As at 1 April 2025	5,546	4,019	9,565

As at 31 March 2026	5,546	4,019	9,565

Depreciation
As at 1 April 2025	5,439	1,566	7,005
Provided during the period	107	1,005	1,112

As at 31 March 2026	5,546	2,571	8,117

Net Book Value
As at 31 March 2026	-	1,448	1,448

As at 1 April 2025	107	2,453	2,560

Page 3

Page 4

Oncoplastic Breast Surgery Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 March 2026

5. Debtors

	2026	2025
	£	£
Due within one year
Trade debtors	6,282	4,589
Prepayments and accrued income	7,582	4,745

	13,864	9,334

6. Creditors: Amounts Falling Due Within One Year

	2026	2025
	£	£
Corporation tax	42,716	40,822
Credit card control	-	(48 )
Accruals and deferred income	3,123	5,045
Directors' loan accounts	3,806	3,865

	49,645	49,684

7. Deferred Taxation

The provision for deferred tax is made up as follows:

	2026	2025
	£	£
Other timing differences	275	486

8. Provisions for Liabilities


	Deferred Tax	Total
	£	£
As at 1 April 2025	486	486
Deferred taxation	(211 )	(211 )

Balance at 31 March 2026	275	275

Provision is made for the potential charge to tax that would arise should the company dispose of its fixed assets at the stated net book value to the extent that this is in excess of the tax written down value.

9. Share Capital

	2026	2025
	£	£
Allotted, Called up and fully paid	200	150

Page 4